Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
for C-Met Exon 14 Mutation
2 locations in Louisville
Sponsor: Haihe Biopharma Co., Ltd.
Sex: All·Age: 18 - 80
Code: NCT04270591·Phase 1, Phase 2·Recruiting·Listed Feb 2020